USD 550
BGICC 2027 covers breast cancer, gynecological oncology, immuno-oncology, precision medicine, cancer diagnostics, surgery, radiotherapy, and systemic treatment. Additional topics include molecular biomarkers, targeted and immune-based therapies, early detection, multidisciplinary cancer management, clinical research, and individualized treatment strategies.
